Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,511 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06781515Recruiting
Hairy cell leukemia disease burden study
This study watches the course of hairy cell leukemia (HCL) in different phases—when first diagnosed, after it comes back, or long after successful treatment. The goal is to better understand the disease and plan future care.
Bologna, BolognaAges 18 years+ - NCT06780826Recruiting
Atezolizumab plus chemo for extensive-stage small cell lung cancer
This trial tests whether adding the immunotherapy drug atezolizumab to standard chemotherapy helps people with extensive-stage small cell lung cancer. It is for those who have not had treatment for this stage yet.
ShanghaiAges 18 years+ - NCT07475182RecruitingEarly Phase 1
Cell therapy for advanced solid tumors with specific proteins
This trial tests a new type of cell therapy (CAR-T and targeted DC cells) for people with advanced solid tumors that have specific proteins. It aims to see if these immune cells can shrink tumors or slow their growth.
Haikou, HainanAges 18–75 - NCT07478224Recruiting
Blood flow restriction training for osteogenesis imperfecta type I
This study tests whether a special type of strength training, called blood flow restriction training, can improve muscle, bone, and quality of life in adults with osteogenesis imperfecta type I.
GhentAges 18–65 - NCT07476352RecruitingEarly Phase 1
Testing ALT001 for Multiple System Atrophy
This early-phase trial tests a new drug called ALT001 for people with multiple system atrophy (MSA). It aims to see if the drug is safe and may help slow the disease.
Beijing, Beijing MunicipalityAges 30–75 - NCT07479056Recruiting
Fexuprazan to prevent stomach bleeding in heart patients on two blood thinners
This trial tests whether fexuprazan can prevent upper gastrointestinal bleeding in people at high risk who need two antiplatelet drugs for at least 6 months after a heart stent. If you are on dual antiplatelet therapy after a stent and have risk factors like older age, low weight, or history of ulcers, this study may help protect your stomach.
Seoul, Eunpyeong-guAges 20 years+ - NCT07472192RecruitingPhase 2
Laser treatment with or without PDRN for facial scars
This study tests if adding a substance called PDRN to a laser treatment helps improve the look of new facial scars better than laser alone. PDRN may help the skin heal more smoothly.
GizaAges 18–50 - NCT07475052Enrolling by invitation
Heart rate monitoring to predict biologic therapy response in IBD
This study tests whether a wearable heart rate monitor can help predict how well biologic medications work for people with Crohn's disease or ulcerative colitis. If you are starting infliximab or vedolizumab for the first time, you may be eligible.
Xi'an, ShaanxiAges 18–75 - NCT07479979RecruitingPhase 1/Phase 2
Study of selinexor with carfilzomib, isatuximab and dexamethasone for relapsed/refractory multiple myeloma
This trial tests a combination of four drugs (selinexor, carfilzomib, isatuximab, and dexamethasone) in patients whose multiple myeloma has come back or stopped responding to prior treatment. The goal is to see if this combination can shrink the cancer and help patients whose disease has high-risk features, like certain chromosome changes.
Madison, WisconsinAges 18 years+ - NCT07478029Recruiting
PEG bowel preparation study for appendectomy patients
This study tests if a bowel-cleaning solution (PEG) works well before colonoscopy. It compares people who have had their appendix removed to those who haven't.
Wuhan, HubeiAges 18–75 - NCT07479966Enrolling by invitation
Brain connectivity and placebo response study
This trial examines how brain connectivity relates to differences in how people respond to placebos. It may help understand individual responses to treatments.
Hamburg, Free and Hanseatic City of HamburgAges 18–35 - NCT07473648Recruiting
A trial of ECT and magnetic seizure therapy for mood disorders
This study compares two types of brain stimulation treatments—electroconvulsive therapy (ECT) and magnetic seizure therapy (MST)—to see which works better for people with certain mental health conditions. It may be an option if you have a mood disorder or vision problems that could be helped by these treatments.
Hefei, AnhuiAges 12–80 - NCT07473635Recruiting
Botox injections for nerve pain in CRPS — an early safety study
This study tests whether a specially targeted injection of botulinum toxin (like Botox) around nerves can help reduce pain from CRPS. It aims to see if the treatment is safe and doable for people with long-lasting CRPS.
Glostrup, Region SjællandAges 18 years+ - NCT07477015Recruiting
Study to find new antibodies in autoimmune encephalitis
This research study looks for new markers in the blood of people with autoimmune encephalitis (a condition where the immune system attacks the brain). It aims to better understand what causes the disease and find new ways to diagnose it.
Rome, RMAges 18 years+ - NCT07476274Recruiting
Study of pneumonia after heart bypass surgery
This trial looks at pneumonia that happens in the hospital after coronary artery bypass surgery. It aims to understand who is at risk and how to better prevent or treat it.
Tomsk, Tomsk OblastAges 18 years+ - NCT07475026RecruitingPhase 3
Combination therapy before surgery for high-risk liver cancer
This trial tests whether a combination of two drugs (tislelizumab and lenvatinib) given before surgery can lower the risk of liver cancer coming back in people with early-stage but high-risk disease.
TianjinAges 18–75 - NCT07472231Recruiting
Game-based therapy for children with lazy eye
This trial tests if a fun, game-based training program can improve vision in children with lazy eye caused by a difference in glasses prescription between the two eyes. It is designed for children ages 4 to 7 who can participate in vision exercises.
Shanghai, Shanghai MunicipalityAges 4–7 - NCT07477821Recruiting
Muscle and brain health study in aging and neurological disorders
This study looks at the link between muscle health and brain function in people with different neurological conditions or healthy aging. It may help researchers understand how muscle changes relate to memory, movement, and thinking problems.
CataniaAges 60 years+ - NCT07476807Enrolling by invitation
Using video calls to check skin reactions from cancer treatment
This study tests if video consultations can safely check skin side effects from chemotherapy or other cancer drugs. If you have a mild to moderate skin rash or reaction, you might be able to have a telemedicine visit instead of going to the hospital.
Sligo, SligoAges Any age - NCT07478198Enrolling by invitation
PLLA injections for facial sagging after weight loss drug use
This trial tests whether PLLA injections can safely improve facial sagging in people who lost weight on GLP-1 drugs. If you are between 30 and 60, have noticeable sagging or smile lines, and have not had other facial treatments recently, this may be an option.
Shanghai, Shanghai MunicipalityAges 30–60 - NCT07479472Recruiting
A study of digestive tract cancers in young adults
This study observes people aged 18-49 with a new gastrointestinal cancer (colorectal, stomach/esophageal, or pancreatic) to learn how their lifestyle habits and tumor characteristics affect their health. By participating, you help researchers understand why these cancers occur in younger adults.
Bologna, BOAges 18–49 - NCT07473206Recruiting
Laughing gas for pain during office hysteroscopy
This study tests whether using laughing gas (nitrous oxide) plus a calming video on a screen can reduce pain and anxiety during a quick procedure to look inside the uterus (hysteroscopy). If you are having this procedure, the trial may help you feel more comfortable.
BiellaAges 25–60 - NCT07480057Recruiting
Bone health changes after liver transplant
This study tracks how liver transplantation affects your bone density and mineral metabolism. It aims to find changes early, which can help prevent fractures later.
New Delhi, National Capital Territory of DelhiAges 18 years+ - NCT07477067Recruiting
Exercise and Protein Use in Type 2 Diabetes
This study looks at how exercise and protein work together in people aged 65 and older, either with or without type 2 diabetes. You will be asked to exercise and may receive a protein supplement to see how your body uses protein.
Urbana, IllinoisAges 65 years+
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,511 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.